Total current assets Total non-current assets Total Assets Total current liabilities Total non- current liabilities Total Shareholders’ Equity Balance as of Balance as of Total Liabilities and Shareholders’ Equity Gross Profit Segment gross profit Operating loss Segment operating loss Net loss Loss before tax Total comprehensive and net loss Comprehensive and net loss Net loss Net loss and comprehensive loss Loss for the period (in Dollars) Balance as of (in Shares) Balance as of (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash provided by (used in) investing activities Net cash provided by financing activities Net increase (decrease) in cash and cash equivalents and restricted cash Cash, cash equivalents and restricted cash at the beginning of the period Cash, cash equivalents and restricted cash at the end of the period Total cash paid Business Combination [Axis] Ownership [Axis] Long-Lived Asset, Class [Axis] Statistical Measurement [Axis] Total consideration fair value Total identifiable net assets acquired Total purchase consideration Total Inventory Liability Class [Axis] Product and Service [Axis] Cost of revenues Cost of revenues Segment cost of revenues Title and Position [Axis] Class of Stock [Axis] Outstanding at beginning of year Outstanding at beginning of year Outstanding at beginning of year Weighted-average exercise price Weighted-average exercise price Class of Warrant or Right [Axis] Exercise Price Range [Axis] Number of options, Outstanding at beginning of year Number of options, Outstanding ending Weighted average Exercise price, Outstanding at beginning of year (in Dollars per share) Weighted average Exercise price, Outstanding ending (in Dollars per share) Award Type [Axis] Segment total operating expenses Other income (expenses) Consolidation Items [Axis] Customer [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Type [Axis] Geographical [Axis] Document Type Document Fiscal Year Focus Entity File Number Entity Registrant Name Entity Central Index Key Amendment Flag Document Period End Date Document Fiscal Period Focus Current Fiscal Year End Date ASSETS Current Assets: Cash and cash equivalents Accounts receivable Other current assets Non-Current Assets: Right of use assets, net Recognized related right-of-use asset Property, plant and equipment, net LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities: Trade accounts payable Contingent consideration liability Deferred revenue Other accounts payable Lease liabilities Financial liabilities at fair market value Financial liabilities at fair value Non-Current Liabilities: Lease liabilities Deferred revenue Royalty-bearing grant liability Shareholders’ Equity: Ordinary shares, Value Ordinary shares, par value (in Dollars per share) Ordinary shares, Authorized (in Shares) Authorized, Ordinary shares Ordinary shares, Issued (in Shares) Ordinary shares, Outstanding (in Shares) Issued and outstanding, Ordinary shares Total number of Ordinary Shares Share capital and additional paid-in capital Accumulated losses Revenues Segment revenues Interest income from deposits Finance income (expenses), net Net loss per ordinary share, basic (in Dollars per share) Basic loss per share (in Dollars per share) Net loss per ordinary share, diluted (in Dollars per share) Diluted loss per share (in Dollars per share) Weighted average number of ordinary shares, basic (in Shares) Weighted average number of Ordinary Shares Weighted average number of ordinary shares, diluted (in Shares) Changes during the six months ended June 30, 2026: Issuance of ordinary shares, pre-funded warrants and ordinary warrants, net Issuance of ordinary shares, pre-funded warrants and ordinary warrants, net (in Shares) Issued shares (in Shares) Issued shares Exercise of options Exercise of options (in Shares) Restricted share unit vesting (in Shares) Restricted share unit vesting Issuance of ordinary shares- commitment fee Issuance of ordinary shares- commitment fee (in Shares) Reclassification of private warrants from liability to equity following change of terms Share-based compensation Share based payment expenses (in Dollars) Exercise of ordinary warrants, pre-funded warrants and private warrants (in Shares) Exercise of ordinary warrants, pre-funded warrants and private warrants Changes during the six months ended June 30, 2025: Issuance of ordinary shares, pursuant to an at-the-market -facility, net Issuance of ordinary shares, pursuant to an at-the-market -facility, net (in Shares) Issued an aggregate shares Exercise of pre funded warrants Exercise of pre funded warrants (in Shares) CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used by operating activities: Depreciation Share based compensation Share based payment – officers and directors Prepayments of lease liabilities Increase in trade accounts payable Increase in other accounts payable Decrease in deferred revenue Financial expenses due to contingent consideration liability at fair value CASH FLOWS FROM INVESTING ACTIVITIES: Sale of property, plant and equipment CASH FLOWS FROM FINANCING ACTIVITIES: Issuance of ordinary shares, pre-funded warrants and ordinary warrants, net Issuance of ordinary shares pursuant to an at-the-market facility, net Gross proceeds from issuance of common stock Gross proceeds (in Dollars) Exercise of warrants and pre-funded warrants, net Exercise of options Effect of exchange rate changes on cash and cash equivalents Restricted Cash Total cash, cash equivalents and restricted cash shown in the statement of cash flows Accrued issuance expenses Reclassification of private warrants from liability to equity following change of terms Issuance of ordinary shares- commitment fee Interest paid Right of use assets, net Right-of-use assets, net Inventory Fixed assets Property and equipment Accounts Receivable Trade receivables Research and development expenses Research and development General and administrative expenses General and administrative Sales and marketing expenses Sales and marketing Taxes on income Capital loss (gain) Revaluation of financial liability at fair value Increase in account receivables Decrease in right of use assets Decrease (increase) in other current assets Decrease (increase) in inventory Unrealized foreign exchange (gain) loss Purchase of property, plant and equipment Business combination of AME and Fabrica Product Lines Change in deposits, net Lease liabilities Lease liabilities Deferred Revenue Deferred revenues Royalty-bearing grant liability Royalty-bearing grant liability Contingent consideration liability Ordinary Share Ordinary Shares [Member] Common Stock [Member] Share capital and Additional Paid in Capital Accumulated losses AME AND FABRICA PRODUCT LINES [Member] GENERAL SIGNIFICANT ACCOUNTING POLICIES Schedule of Consolidated Financial Statements and Subsidiaries Country of Incorporation Percentage Owned Schedule of Depreciation on Straight-Line Method, Over the Estimated Useful Life of the Assets Annual depreciation rates SIGNIFICANT EVENTS DURING THE REPORTING PERIOD BUSINESS COMBINATION Schedule of Preliminary Fair Value of the Consideration Transferred Consideration: Cash consideration Contingent consideration liability Identifiable assets acquired and liabilities assumed Goodwill Schedule of Unaudited Pro Forma Results